On July 30, 2018, FDA announced that it had warned numerous companies to stop marketing laser devices for procedures often and colloquially referred to as “vaginal rejuvenation.” As succinctly explained by FDA Commissioner Dr. Scott Gottlieb, the FDA had recently become aware of a growing number of manufacturers marketing “vaginal rejuvenation” devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence or sexual function. The procedures use lasers and other energy-based devices to destroy or reshape vaginal tissue. These products have serious risks and don’t have adequate evidence to support their use for these purposes. We are deeply concerned women are being harmed. Further, we published a piece concerning the FDA announcement last week as well. A full copy of the MonaLisa Touch Lawsuit (Referred to herein as: MonaLisa Touch Class Action, Cynosure Class Action, Cynosure Lawsuit) is below:
Editor’s note on the MonaLisa Touch Class Action Lawsuit:
This piece is written about the recent Cynosure Lawsuit. If you are considered eligible to be among the class of consumers described in the class action, you may eventually be able to participate in receiving any compensation the court may award.
If you believe that what is alleged in the MonaLisa Touch Lawsuit has affected you, please don’t hesitate to reach out to us. We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join the consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter, Facebook, Instagram, LinkedIn, or even connect with us directly on our website! We look forward to hearing from all of you.
The case can be searched for under the name: Three R LLC v Cynosure, Inc. (1:18-cv-30122-PBS).